{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:39:21Z","timestamp":1760013561392,"version":"3.41.2"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007793","name":"Stiftelsen Kristian Gerhard Jebsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.rpth.2024.102636","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T08:03:03Z","timestamp":1732608183000},"page":"102636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of plasma levels of factor VIII according to procoagulant phospholipids on the risk of future venous thromboembolism"],"prefix":"10.1016","volume":"9","author":[{"given":"Magnus S.","family":"Edvardsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen-Sofie","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thor","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadezhda","family":"Latysheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e5l","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omri","family":"Snir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0872-6645","authenticated-orcid":false,"given":"V\u00e2nia M.","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John-Bjarne","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2024.102636_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","article-title":"Venous thromboembolism","volume":"398","author":"Khan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2024.102636_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10654-017-0238-y","article-title":"Time trends in incidence rates of venous thromboembolism in a large cohort recruited from the general population","volume":"32","author":"Arshad","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.rpth.2024.102636_bib3","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/jth.13336","article-title":"Subcommittees on Control of Anticoagulation, and Predictive and Diagnostic Variables in Thrombotic Disease. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH","volume":"14","author":"Kearon","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102636_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bjh.15872","article-title":"Advances in understanding the molecular mechanisms that maintain normal haemostasis","volume":"186","author":"O'Donnell","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102636_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","article-title":"Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis","volume":"345","author":"Koster","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2024.102636_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.thromres.2023.06.026","article-title":"Plasma levels of coagulation factors VIII and IX and risk of venous thromboembolism: systematic review and meta-analysis","volume":"229","author":"Lowe","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2024.102636_bib7","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCULATIONAHA.118.034532","article-title":"Genome-wide association transethnic meta-analyses identifies novel associations regulating coagulation factor VIII and von Willebrand factor plasma levels","volume":"139","author":"Sabater-Lleal","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2024.102636_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jvssci.2021.08.002","article-title":"Role of von Willebrand factor in venous thromboembolic disease","volume":"3","author":"Michels","year":"2022","journal-title":"JVS Vasc Sci"},{"key":"10.1016\/j.rpth.2024.102636_bib9","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1016\/j.jtha.2023.06.022","article-title":"Combined effect of high factor VIII levels and high mean platelet volume on the risk of future incident venous thromboembolism","volume":"21","author":"Hansen","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102636_bib10","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood.2021011494","article-title":"Combined effects of plasma von Willebrand factor and platelet measures on the risk of incident venous thromboembolism","volume":"138","author":"Edvardsen","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102636_bib11","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/jth.14788","article-title":"Large and small platelets\u2014(When) do they differ?","volume":"18","author":"Handtke","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102636_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2796.2004.01444.x","article-title":"Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases","volume":"257","author":"Dahlback","year":"2005","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.rpth.2024.102636_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2141.2007.06514.x","article-title":"Plasma microparticles and vascular disorders","volume":"137","author":"Lynch","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102636_bib14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.thromres.2011.08.020","article-title":"Circulating microparticles and risk of venous thromboembolism","volume":"129","author":"Bucciarelli","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2024.102636_bib15","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.jtha.2024.01.004","article-title":"Extracellular vesicles from activated platelets possess a phospholipid-rich biomolecular profile and enhance prothrombinase activity","volume":"22","author":"Guerreiro","year":"2024","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102636_bib16","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/CIRCRESAHA.110.233056","article-title":"Microparticles in hemostasis and thrombosis","volume":"108","author":"Owens","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.rpth.2024.102636_bib17","doi-asserted-by":"crossref","first-page":"e12640","DOI":"10.1002\/rth2.12640","article-title":"Plasma procoagulant phospholipid clotting time and venous thromboembolism risk","volume":"5","author":"Ramberg","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102636_bib18","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ije\/dyr049","article-title":"Cohort profile: the Tromso Study","volume":"41","author":"Jacobsen","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.rpth.2024.102636_bib19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1182\/bloodadvances.2020003135","article-title":"Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism","volume":"5","author":"Edvardsen","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2024.102636_bib20","doi-asserted-by":"crossref","first-page":"9341","DOI":"10.1038\/s41598-021-88835-y","article-title":"A\u00a0modified clot-based assay to measure negatively charged procoagulant phospholipids","volume":"11","author":"Ramberg","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.rpth.2024.102636_bib21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10654-005-7835-x","article-title":"Calculating measures of biological interaction","volume":"20","author":"Andersson","year":"2005","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.rpth.2024.102636_bib22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/oxfordjournals.aje.a010013","article-title":"Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies","volume":"150","author":"Clarke","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.rpth.2024.102636_bib23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1160\/TH06-06-0313","article-title":"Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets","volume":"97","author":"Sinauridze","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102636_bib24","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1160\/TH09-03-0180","article-title":"Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram","volume":"102","author":"Machlus","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102636_bib25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.thromres.2018.10.020","article-title":"Elevated coagulation factor levels affect the tissue factor-threshold in thrombin generation","volume":"172","author":"Rietveld","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2024.102636_bib26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.thromres.2007.04.012","article-title":"The endogenous thrombin potential and the risk of venous thromboembolism","volume":"121","author":"Tripodi","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2024.102636_bib27","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.thromres.2010.01.036","article-title":"Formation of procoagulant microparticles and properties","volume":"125","author":"Freyssinet","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2024.102636_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/ATVBAHA.109.200956","article-title":"Cellular mechanisms underlying the formation of circulating microparticles","volume":"31","author":"Morel","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924003315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924003315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T23:49:47Z","timestamp":1751932187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037924003315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2475037924003315"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102636","relation":{},"ISSN":["2475-0379"],"issn-type":[{"type":"print","value":"2475-0379"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of plasma levels of factor VIII according to procoagulant phospholipids on the risk of future venous thromboembolism","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102636","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102636"}}